Maze Therapeutics, Inc. (MAZE)
26.69
-1.19
(-4.27%)
USD |
NASDAQ |
Apr 10, 16:00
26.26
-0.43
(-1.61%)
After-Hours: 20:00
Maze Therapeutics Total Liabilities (Quarterly) : 42.16M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CDT Equity, Inc. | 4.274M |
| LENZ Therapeutics, Inc. | 21.54M |
| Liminatus Pharma, Inc. | 10.33M |
| Oruka Therapeutics, Inc. | 16.69M |
| MapLight Therapeutics, Inc. | 21.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 397.13M |
| Shareholders Equity (Quarterly) | 354.97M |
| Debt to Equity Ratio | 0.0657 |
| Current Ratio | 15.50 |
| Net Debt Paydown Yield | 0.55% |